Calandra T - Search Results

1

Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock.

Landmann R, Zimmerli W, Sansano S, Link S, Hahn A, Glauser MP, Calandra T. Landmann R, et al. Among authors: calandra t. J Infect Dis. 1995 Mar;171(3):639-44. doi: 10.1093/infdis/171.3.639. J Infect Dis. 1995. PMID: 7533199

2

Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.

Calandra T, Baumgartner JD, Glauser MP. Calandra T, et al. Prog Clin Biol Res. 1991;367:141-59. Prog Clin Biol Res. 1991. PMID: 1924424 Review.

3

Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group.

Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, Verhoef J, Glauser MP. Calandra T, et al. J Infect Dis. 1990 May;161(5):982-7. doi: 10.1093/infdis/161.5.982. J Infect Dis. 1990. PMID: 2109023 Clinical Trial.

4

Cytokines and septic shock.

Calandra T, Glauser MP. Calandra T, et al. Diagn Microbiol Infect Dis. 1990 Sep-Oct;13(5):377-81. doi: 10.1016/0732-8893(90)90006-h. Diagn Microbiol Infect Dis. 1990. PMID: 2126495 Review. No abstract available.

5

Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.

Calandra T, Glauser MP, Schellekens J, Verhoef J. Calandra T, et al. J Infect Dis. 1988 Aug;158(2):312-9. doi: 10.1093/infdis/158.2.312. J Infect Dis. 1988. PMID: 3136210 Clinical Trial.

6

Soluble CD14 in septic shock.

Landmann R, Calandra T, Zimmerli W. Landmann R, et al. Among authors: calandra t. Prog Clin Biol Res. 1995;392:375-80. Prog Clin Biol Res. 1995. PMID: 8524945 No abstract available.

7

Molecular basis of host-pathogen interaction in septic shock.

Heumann D, Glauser MP, Calandra T. Heumann D, et al. Among authors: calandra t. Curr Opin Microbiol. 1998 Feb;1(1):49-55. doi: 10.1016/s1369-5274(98)80142-2. Curr Opin Microbiol. 1998. PMID: 10066457 Review.

8

Monocyte deactivation in septic shock.

Heumann D, Glauser MP, Calandra T. Heumann D, et al. Among authors: calandra t. Curr Opin Infect Dis. 1998 Jun;11(3):279-83. doi: 10.1097/00001432-199806000-00003. Curr Opin Infect Dis. 1998. PMID: 17033392

9

High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group.

Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP. Calandra T, et al. Am J Med. 1991 Jul;91(1):23-9. doi: 10.1016/0002-9343(91)90069-a. Am J Med. 1991. PMID: 1907101

10

Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5.

Baumgartner JD, Heumann D, Calandra T, Glauser MP. Baumgartner JD, et al. Among authors: calandra t. J Infect Dis. 1991 Apr;163(4):769-72. doi: 10.1093/infdis/163.4.769. J Infect Dis. 1991. PMID: 2010630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters